Literature DB >> 23419425

Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.

A L Brantsæter1, K W Whitworth, T A Ydersbond, L S Haug, M Haugen, H K Knutsen, C Thomsen, H M Meltzer, G Becher, A Sabaredzovic, J A Hoppin, M Eggesbø, M P Longnecker.   

Abstract

BACKGROUND: Perfluoroalkyl substances (PFASs) are widespread pollutants that have been associated with adverse health effects although not on a consistent basis. Diet has been considered the main source of exposure. The aim of the present study was to identify determinants of four plasma PFASs in pregnant Norwegian women.
METHODS: This study is based in the Norwegian Mother and Child Cohort Study (MoBa) conducted by the Norwegian Institute of Public Health. Our sample included 487 women who enrolled in MoBa from 2003 to 2004. A questionnaire regarding sociodemographic, medical, and reproductive history was completed at 17 weeks of gestation and a dietary questionnaire was completed at 22 weeks of gestation. Maternal plasma samples were obtained around 17 weeks of gestation. Plasma concentrations of four PFASs (perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), perfluorohexane sulfonate (PFHxS), and perfluorononanoate (PFNA)) were examined in relation to demographic, lifestyle, dietary, and pregnancy-related covariates. Predictors were identified by optimizing multiple linear regression models using Akaike's information criterion (AIC).
RESULTS: Parity was the determinant with the largest influence on plasma PFAS concentrations, with r(2) between 0.09 and 0.32 in simple regression models. In optimal multivariate models, when compared to nulliparous women, parous women had 46%, 70%, 19%, and 62% lower concentrations of PFOS, PFOA, PFHxS, and PFNA respectively (p<0.001 except for PFHxS, p<0.01). In all these models, duration of breastfeeding was associated with reduced PFAS levels. PFOA showed the largest reduction from breastfeeding, with a 2-3% reduction per month of breastfeeding in typical cases. Levels of PFOS, PFOA, and PFNA increased with time since most recent pregnancy. While pregnancy-related factors were the most important predictors, diet was a significant factor explaining up to 4% of the variance. One quartile increase in estimated dietary PFAS intake was associated with plasma PFOS, PFOA, PFHxS, and PFNA concentration increases of 7.2%, 3.3%, 5.8% and 9.8%, respectively, resulting in small, although non-trivial absolute changes in PFAS concentrations.
CONCLUSION: Previous pregnancies and breastfeeding duration were the most important determinants of PFASs in this sample of pregnant women.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23419425      PMCID: PMC3605228          DOI: 10.1016/j.envint.2012.12.014

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  57 in total

1.  Serial studies of renal function during pregnancy and the puerperium in normal women.

Authors:  E A SIMS; K E KRANTZ
Journal:  J Clin Invest       Date:  1958-12       Impact factor: 14.808

2.  Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives.

Authors:  Melvin E Andersen; Harvey J Clewell; Yu-Mei Tan; John L Butenhoff; Geary W Olsen
Journal:  Toxicology       Date:  2006-08-12       Impact factor: 4.221

3.  Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Per Magnus; Lorentz M Irgens; Kjell Haug; Wenche Nystad; Rolv Skjaerven; Camilla Stoltenberg
Journal:  Int J Epidemiol       Date:  2006-08-22       Impact factor: 7.196

Review 4.  Adjustment for total energy intake in epidemiologic studies.

Authors:  W C Willett; G R Howe; L H Kushi
Journal:  Am J Clin Nutr       Date:  1997-04       Impact factor: 7.045

5.  Plasma volume and glomerular filtration rate in pregnancy and their relation to differences in fetal growth.

Authors:  H M Gibson
Journal:  J Obstet Gynaecol Br Commonw       Date:  1973-12

6.  Retrospective monitoring of perfluorocarboxylates and perfluorosulfonates in human plasma archived by the German Environmental Specimen Bank.

Authors:  Christa Schröter-Kermani; Josef Müller; Heinrich Jürling; André Conrad; Christoph Schulte
Journal:  Int J Hyg Environ Health       Date:  2012-09-21       Impact factor: 5.840

7.  Serial changes in renal haemodynamics during normal human pregnancy.

Authors:  W Dunlop
Journal:  Br J Obstet Gynaecol       Date:  1981-01

8.  Glomerular filtration rate in pregnancy: a study in normal subjects and in patients with hypertension, preeclampsia and diabetes.

Authors:  E Krutzén; P Olofsson; S E Bäck; P Nilsson-Ehle
Journal:  Scand J Clin Lab Invest       Date:  1992-09       Impact factor: 1.713

9.  Binding of perfluorinated fatty acids to serum proteins.

Authors:  Paul D Jones; Wenyue Hu; Wim De Coen; John L Newsted; John P Giesy
Journal:  Environ Toxicol Chem       Date:  2003-11       Impact factor: 3.742

10.  Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden.

Authors:  Anna Kärrman; Ingrid Ericson; Bert van Bavel; Per Ola Darnerud; Marie Aune; Anders Glynn; Sanna Lignell; Gunilla Lindström
Journal:  Environ Health Perspect       Date:  2006-11-28       Impact factor: 9.031

View more
  47 in total

1.  Breastfeeding as a Predictor of Serum Concentrations of Per- and Polyfluorinated Alkyl Substances in Reproductive-Aged Women and Young Children: A Rapid Systematic Review.

Authors:  Brianna N VanNoy; Juleen Lam; Ami R Zota
Journal:  Curr Environ Health Rep       Date:  2018-06

2.  Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood.

Authors:  Samantha L Kingsley; Melissa N Eliot; Karl T Kelsey; Antonia M Calafat; Shelley Ehrlich; Bruce P Lanphear; Aimin Chen; Joseph M Braun
Journal:  Environ Res       Date:  2018-05-07       Impact factor: 6.498

3.  Brief Report: Plasma Concentrations of Perfluorooctane Sulfonamide and Time-to-pregnancy Among Primiparous Women.

Authors:  Kristina W Whitworth; Line S Haug; Azemira Sabaredzovic; Merete Eggesbo; Matthew P Longnecker
Journal:  Epidemiology       Date:  2016-09       Impact factor: 4.822

4.  Temporal trends and determinants of serum concentrations of per- and polyfluoroalkyl substances among Northern California mothers with a young child, 2009-2016.

Authors:  Kyunghoon Kim; Deborah H Bennett; Antonia M Calafat; Irva Hertz-Picciotto; Hyeong-Moo Shin
Journal:  Environ Res       Date:  2020-04-09       Impact factor: 6.498

5.  Demographic, Reproductive, and Dietary Determinants of Perfluorooctane Sulfonic (PFOS) and Perfluorooctanoic Acid (PFOA) Concentrations in Human Colostrum.

Authors:  Todd A Jusko; Marina Oktapodas; L'ubica Palkovičová Murinová; Katarina Babinská; Jana Babjaková; Marc-André Verner; Jamie C DeWitt; Kelly Thevenet-Morrison; Kamil Čonka; Beata Drobná; Jana Chovancová; Sally W Thurston; B Paige Lawrence; Ann M Dozier; Kirsi M Järvinen; Henrieta Patayová; Tomáš Trnovec; Juliette Legler; Irva Hertz-Picciotto; Marja H Lamoree
Journal:  Environ Sci Technol       Date:  2016-06-14       Impact factor: 9.028

6.  Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.

Authors:  Elise L Rush; Alison B Singer; Matthew P Longnecker; Line S Haug; Azemira Sabaredzovic; Elaine Symanski; Kristina W Whitworth
Journal:  Environ Int       Date:  2017-12-20       Impact factor: 9.621

7.  Prenatal exposure to perfluorodecanoic acid is associated with lower circulating concentration of adrenal steroid metabolites during mini puberty in human female infants. The Odense Child Cohort.

Authors:  Richard Christian Jensen; Dorte Glintborg; Clara Amalie Gade Timmermann; Flemming Nielsen; Henriette Boye Kyhl; Hanne Frederiksen; Anna-Maria Andersson; Anders Juul; Johannes J Sidelmann; Helle Raun Andersen; Philippe Grandjean; Marianne S Andersen; Tina Kold Jensen
Journal:  Environ Res       Date:  2019-12-31       Impact factor: 6.498

Review 8.  Developmental Exposures to Perfluoroalkyl Substances (PFASs): An Update of Associated Health Outcomes.

Authors:  Zeyan Liew; Houman Goudarzi; Youssef Oulhote
Journal:  Curr Environ Health Rep       Date:  2018-03

9.  Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.

Authors:  Anne P Starling; Stephanie M Engel; David B Richardson; Donna D Baird; Line S Haug; Alison M Stuebe; Kari Klungsøyr; Quaker Harmon; Georg Becher; Cathrine Thomsen; Azemira Sabaredzovic; Merete Eggesbø; Jane A Hoppin; Gregory S Travlos; Ralph E Wilson; Lill I Trogstad; Per Magnus; Matthew P Longnecker
Journal:  Am J Epidemiol       Date:  2014-02-20       Impact factor: 4.897

10.  Per- and Polyfluoroalkyl Substance Exposure, Gestational Weight Gain, and Postpartum Weight Changes in Project Viva.

Authors:  Susanna D Mitro; Sharon K Sagiv; Sheryl L Rifas-Shiman; Antonia M Calafat; Abby F Fleisch; Lindsay M Jaacks; Paige L Williams; Emily Oken; Tamarra M James-Todd
Journal:  Obesity (Silver Spring)       Date:  2020-10       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.